Analyst consensus rating
Guardant Health Analyst Rating: Strong Buy
Direct answer
Guardant Health's consensus rating is Strong Buy.
25 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $202.24.
Forecast evidence checked November 3, 2026.
Get free Guardant Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $170.73
- Average price target
- $202.24
- High price target
- $240.00
- Low price target
- $105.00
- Low target gap
- -38.5%
- Target upside
- +18.5%
- High target gap
- +40.6%
- Target range width
- 79.1%
- Consensus rating
- Strong Buy
- Analysts
- 25
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Guardant Health?
Guardant Health has a verified Strong Buy consensus. The same dataset has an average price target of $202.24.
How far are Guardant Health's low and high targets from the recorded price?
The low target implies -38.5%, while the high target implies +40.6%.
How many analysts are included in Guardant Health's consensus?
The verified consensus includes 25 analysts.
How is Guardant Health's target upside or downside calculated?
The average target of $202.24 is divided by the recorded price of $170.73, then one is subtracted to produce +18.5%. This does not guarantee a future return.
When was Guardant Health's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.